Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-04-16WISER After Ovarian Cancer - Exercise Pilot Study
-
CLINICAL_TRIALS study record update · 2020-04-09A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Patients With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received Three or Four Previous Chemotherapy Regimens
-
CLINICAL_TRIALS study record update · 2020-04-08A Phase II Study Of OSI-774 (NSC 718781) Given In Combination With Carboplatin In Patients With Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-04-07VM110 in Detection of Microscopic Tumors: A Phase I Study
-
CLINICAL_TRIALS study record update · 2020-04-06A Phase I Study of NX 211 in Combination With Cisplatin Given as an IV Infusion Days 1, 2, and 3 Every 3 Weeks in Patients With Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-04-06Randomized Phase II Study Of NX 211 Given By Two Different Intravenous Schedules In Advanced And/Or Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-04-06Phase II Study of CGP 69846A (ISIS 5132) in Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-04-02Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis
-
CLINICAL_TRIALS study record update · 2020-04-02A Phase III Study of Cisplatin Plus Topotecan Followed by Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Carboplatin as First Line Chemotherapy in Women With Newly Diagnosed Advanced Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-04-02Access to Fast Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-04-01Prognostic Value of Her2neu and EGFR in Primary Ovarian High Grade Serous Carcinoma.
-
CLINICAL_TRIALS study record update · 2020-03-25A Phase 2, Multicenter, Open-label, Single-arm Study to Evaluate the Safety of Niraparib in Japanese Patients With Platinum-sensitive, Relapsed Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Achieved CR or PR in the Last Chemotherapy Containing Platinum-based Anticancer Agents
-
CLINICAL_TRIALS study record update · 2020-03-20Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin (PM01183) in Combination With Weekly Paclitaxel, With or Without Bevacizumab, in Patients With Selected Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-03-19A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer
-
CLINICAL_TRIALS study record update · 2020-03-18Phase Ib Trial of Two Folate Binding Protein (FBP) Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients
-
CLINICAL_TRIALS study record update · 2020-03-17A Phase II Study of Pembrolizumab With Cisplatin and Gemcitabine Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-03-12A Phase 3 Study of Safety and Efficacy of Karenitecin Versus Topotecan Administered for 5 Consecutive Days Every 3 Weeks in Patients With Advanced Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-03-12Phase I Dose-Escalation Parallel Studies of Intraperitoneal Oxaliplatin With Intravenous Docetaxel and Intravenous Oxaliplatin With Intraperitoneal Docetaxel in Platinum-Sensitive or Platinum-Resistant Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
-
CLINICAL_TRIALS study record update · 2020-03-11Phase I Study of the Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 With Blocking of Autocrine Loops VEGFR1/2/3
-
CLINICAL_TRIALS study record update · 2020-03-09Feasibility of Frailty Assessment and Implementation of Protocol-led Geriatric Interventions in Women Over the Age of 70 With Epithelial Ovarian Cancer in the Oncology Clinic (FAIR-O)
-
CLINICAL_TRIALS study record update · 2020-03-05Phase III Randomized Clinical Trial of Lurbinectedin (PM01183) Versus Pegylated Liposomal Doxorubicin or Topotecan in Patients With Platinum-resistant Ovarian Cancer (CORAIL Trial)
-
CLINICAL_TRIALS study record update · 2020-03-04Randomized, Multicentre Trial for Lymphadenectomy In Ovarian Neoplasms
-
CLINICAL_TRIALS study record update · 2020-03-02An Expanded Access Program for AM0010 (Pegilodecakin) Subcutaneous Injection
-
CLINICAL_TRIALS study record update · 2020-02-28Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention
-
CLINICAL_TRIALS study record update · 2020-02-27A Pilot Trial to Study the Availability and Effect of Post-OP IV Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer, Cells Retrieved From the Peritoneal Cavity